CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: drug added to transplant process
Disease control OngoingThis study is testing the safety of adding a drug called venetoclax to the standard treatment given before a bone marrow transplant for people with high-risk blood cancers like AML and MDS. It also tests giving venetoclax with other drugs after the transplant to try to prevent th…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial targets specific genetic flaw in blood cancer
Disease control OngoingThis study is testing if the drug cobimetinib can help control a specific type of blood cancer called Chronic Myelomonocytic Leukemia (CMML) in adults. It is for people who are newly diagnosed or whose previous treatment has stopped working, and whose cancer has specific genetic …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC